Heart failure guidelines implementation: Lifting barriers using registries and networks

di Keramida, Kalliopi, Filippatos, Gerasimos
Pubblicato in Anatol J Cardiol (2020)

Clinical development plan for regenerative therapy in heart failure

di Terzic, Andre, Behfar, Atta, Filippatos, Gerasimos
Pubblicato in Eur J Heart Fail (2016)

Cardio‐oncology services during the COVID‐19 pandemic: practical considerations and challenges

di Farmakis, Dimitrios, Keramida, Kalliopi, Filippatos, Gerasimos
Pubblicato in Eur J Heart Fail (2020)

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice

di Filippatos, Gerasimos, Farmakis, Dimitrios, Parissis, John, Lekakis, John
Pubblicato in BMC Med (2015)

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice

di Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Anker, Stefan D., Packer, Milton
Pubblicato in Eur Heart J (2020)

Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies

di Anker, Stefan D., Ponikowski, Piotr, Mitrovic, Veselin, Peacock, W. Frank, Filippatos, Gerasimos
Pubblicato in Eur Heart J (2015)

Pulmonary Oedema—Therapeutic Targets

di Chioncel, Ovidiu, Collins, Sean P, Ambrosy, Andrew P, Gheorghiade, Mihai, Filippatos, Gerasimos
Pubblicato in Card Fail Rev (2015)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function

di Tschöpe, Carsten, Butler, Javed, Farmakis, Dimitrios, Morley, Deborah, Rao, Ishu, Filippatos, Gerasimos
Pubblicato in ESC Heart Fail (2020)

Fas induces apoptosis in human coronary artery endothelial cells in vitro

di Filippatos, Gerasimos, Ang, Edmund, Gidea, Claudia, Dincer, Erhan, Wang, Rongqi, Uhal, Bruce D
Pubblicazione 2004

Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study

di Campbell, Ruth C., Sui, Xuemei, Filippatos, Gerasimos, Love, Thomas E., Wahle, Christy, Sanders, Paul W., Ahmed, Ali
Pubblicazione 2009

Telephone based survey in adults with congenital heart disease during COVID-19 pandemic

di Frogoudaki, Alexandra A., Farmakis, Dimitrios, Tsounis, Dimitrios, Liori, Sotiria, Stamoulis, Konstadinos, Ikonomidis, Ignatios, Filippatos, Gerasimos, Parissis, John
Pubblicato in Cardiol J (2020)

Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure

di Parissis, John T., Nikolaou, Maria, Farmakis, Dimitrios, Paraskevaidis, Ioannis A., Bistola, Vassiliki, Venetsanou, Koula, Katsaras, Dimitrios, Filippatos, Gerasimos, Kremastinos, Dimitrios T.
Pubblicazione 2009

Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease

di Frogoudaki, Alexandra A., Pantelakis, Ioannis, Bistola, Vasiliki, Kroupis, Christos, Birba, Dionysia, Ikonomidis, Ignatios, Alexopoulos, Dimitrios, Filippatos, Gerasimos, Parissis, John
Pubblicato in Medicina (Kaunas) (2020)

Effect of Serum Insulin on the Association between Hyperuricemia and Incident Heart Failure

di Desai, Ravi V., Ahmed, Mustafa I., Fonarow, Gregg C., Filippatos, Gerasimos S., White, Michel, Aban, Inmaculada B., Aronow, Wilbert S., Ahmed, Ali
Pubblicazione 2010

Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry

di Cowie, Martin R., Schöpe, Jakob, Wagenpfeil, Stefan, Tavazzi, Luigi, Böhm, Michael, Ponikowski, Piotr, Anker, Stefan D., Filippatos, Gerasimos S., Komajda, Michel
Pubblicato in ESC Heart Fail (2021)

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney dise...

di Pitt, Bertram, Kober, Lars, Ponikowski, Piotr, Gheorghiade, Mihai, Filippatos, Gerasimos, Krum, Henry, Nowack, Christina, Kolkhof, Peter, Kim, So-Young, Zannad, Faiez
Pubblicazione 2013

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

di Mebazaa, Alexandre, Nieminen, Markku S., Filippatos, Gerasimos S., Cleland, John G., Salon, Jeffrey E., Thakkar, Roopal, Padley, Robert J., Huang, Bidan, Cohen-Solal, Alain
Pubblicazione 2009

Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses

di Marvaki, Apostolia, Kolovou, Vana, Katsiki, Niki, Boutsikou, Maria, Kotanidou, Anastasia, Orfanos, Stylianos, Filippatos, Gerasimos, Marvaki, Katerina, Koumoulidis, Anastasios, Mavrogeni, Sophie, Kolovou, Genovefa
Pubblicazione 2014

Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing

di Filippatos, Gerasimos, Birnie, David, Gold, Michael R., Gerritse, Bart, Hersi, Ahmad, Jacobs, Sandra, Kusano, Kengo, Leclercq, Christophe, Mullens, Wilfried, Wilkoff, Bruce L.
Pubblicato in Eur J Heart Fail (2017)

Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy

di Okonko, Darlington O., Jouhra, Fadi, Abu‐Own, Huda, Filippatos, Gerasimos, Colet, Josep Comin, Suki, Chainey, Mori, Claudio, Ponikowski, Piotr, Anker, Stefan D.
Pubblicato in ESC Heart Fail (2019)